Real-revenue cases
PeptideTrack is an iOS subscription app for people running peptide, GLP-1, or TRT protocols: dose logging on a reminder calendar, bloodwork uploads with automatic out-of-range flags, plus body metrics and progress photos. It charges via in-app subscription, Stripe-verified at $1,582 per month.
01
The old behavior (inferred) is tracking injections and lab results by hand; a tool combining reminders with automatic lab flagging addresses a recurring need, and Stripe-verified recurring revenue shows people pay repeatedly. Still, $1,582/month is small scale and there's no retention data, so stickiness is unproven.
Individuals on peptide, GLP-1, or TRT protocols pay a recurring iOS in-app subscription; the source doesn't disclose pricing.
Not mentioned in the source.
02
Not mentioned in the source.
03
Not an AI product itself (no AI is mentioned in the source), but the play transfers: whenever a new behavior takes off — GLP-1 adoption, everyday AI tool use — companion subscription tools for logging, reminders, and compliance ride that growth. AI operators can look for AI workflows still managed via notes and spreadsheets, then build the tracking layer.
04
Revenue basis · Stripe-verified (TrustMRR)
The source page text is empty: no user counts, subscription pricing, acquisition channels, or retention data.
The $1,582/month is Stripe-verified but comes with no trend data, so it's unclear whether this is early growth or a plateau.
No detail on whether the out-of-range flagging is rule-based or model-based, so the product's technical depth and copyability can't be assessed.